Skip to main content

Canopy Growth Corp.’s quarterly revenue fell to $90.5-million, down 4 per cent from the prior quarter and well below analyst expectations.

The company also reported a quarterly net loss of $1.28-billion, or $3.70 per share, on Wednesday evening. Most of this was attributed to a one-time charge related to revaluing warrants held by Constellation Brands Inc., which holds a major stake in the company. The company’s operating loss was $123.1-million, an improvement from the $174.5-million operating loss in the preceding quarter.

Shares of the Smith Falls, Ont.-based licensed cannabis producer were down 11 per cent in after-hours trading.

Story continues below advertisement

The company’s net revenue in the three months to June 30 fell short of the analyst consensus estimate of around $111-million. Sales were also down from the previous quarter, when Canopy posted net revenue $94.1-million.

Canopy sold $74.1-million worth of cannabis in Canada in the quarter, mostly into the recreational market, and $10.5-million worth of cannabis internationally.

The company’s gross margin on sales was 15 per cent, which is similar to the preceding quarter, but down significantly from the 43 per cent gross margin it posted in the same quarter a year ago.

“The lower gross margin percentage in Q1 2020 was primarily attributable to the impact of operating costs of $16.2-million relating to facilities not yet cultivating cannabis or producing cannabis-related products, or which had under-utilized capacity that resulted in adjustments related to the net realizable value of inventory,” the company said.

Canaccord Genuity Corp. analyst Matt Bottomley said that the $1.17-billion “loss on extinguishment of warrants,” is the result of an accounting calculation, related how far the price of Canopy’s stock is from the exercise price of warrants owned by Constellation Brands.

“It’s a non-cash charge, so it’s really irrelevant from the underlying business. It’s basically an accounting treatment for the fair value change based on how Canopy’s stock traded, relative to what Constellation would buy it back for if it came into the money [with its warrants],” said Mr. Bottomley.

Still, Canopy’s quarter fell short of expectations, said Mr. Bottomley.

Story continues below advertisement

“They did see a decline in their net cannabis sales last quarter, so I thought they’d make a new high, but … they’re still below what they did two quarters ago [in revenue], which I find very surprising because there is more retail stores that have opened and their harvest is certainly increasing quarter over quarter," Mr. Bottomley said.

In early July, Canopy fired co-founder and former chief executive Bruce Linton – one of the cannabis industry’s most prominent executives who charted an aggressive course of acquisitions. Mark Zekulin, formerly co-CEO with Mr. Linton, was appointed interim-CEO.

The lower-than-expected sales occurred despite the company selling 10,549 kilogram equivalents of cannabis, an increase of 13 per cent from the prior quarter.

This was partly due to an $6.4-million adjustment Canopy made to net revenues to account for the expectation that some of its oil products will be returned unsold.

“We believe that the risk of an over-supply of certain oil and softgel formats may exist in certain markets due, in part, to incomplete retail platforms in most provinces,” the company said.

“We had previously flagged the buildup of supply at provinces impacting potential follow-on orders. With today’s release, which cited the potential for product returns, we see the implications of a build as ultimately worse than we expected. This will likely take much of the Street off guard,” said Royal Bank analyst Douglas Miehm in a note.

Story continues below advertisement

Go deeper into the industry with Cannabis Professional, The Globe and Mail's authoritative subscription news service.


Buy Now Start your 14-day trial

Related topics

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter